SAN CLEMENTE, CA--(Marketwire - October 29, 2008) - Micro Imaging Technology, Inc. (
OTCBB:
MMTC), the developer of a patented non-biological based system which can
currently identify up to 23 species of bacteria in a matter of minutes and
at a cost of pennies per test, announced the appointment of Gary DeMel to
the Board of Directors and as a member of the executive team.
"Gary is an outstanding addition to MIT's team and as a Board Member will
also be involved in the day-to-day management of our growth as we bring a
unique technology into applications that include identification of
pathogens in food products, uses in clinical and medical diagnostics and
water quality testing," stated Michael Brennan, Chairman and CEO. "Gary's
background in sales, strategic planning and business development is a
perfect fit as we expand our efforts to meet an aggressive revenue plan for
the coming year. Further, his commitment to a significant investment in the
Company speaks for the assurance of a long-term relationship."
About Gary DeMel:
Mr. DeMel is a twenty-seven-year veteran of the semiconductor and high-tech
industries and was most recently the President and CEO of Earth First
Industries (EFI) where he assisted in developing and patenting its
intellectual properties, while commercializing products for Fortune 100
companies. EFI is currently positioned as the worldwide leader in natural /
alterative bio-packaging materials. Prior to that, and for more than twenty
years, he held senior management positions within Level One Communications,
Inc. and Intel in driving their efforts into the worldwide leadership
position in wireless and networking products. Gary, as VP of Business
Development and Senior Director of worldwide sales, created and directed
most of Intel's strategic worldwide partnerships and was responsible for
their most successful investments in leading-edge startups, including:
Level One Communications / Intel Corp., Tarari Inc. / LSI logic, and ATI
Technologies / AMD.
About Micro Imaging Technology:
The Company has developed and patented a technology for rapid microbial
detection and identification. The MIT System is non-biological, totally
GREEN, and not reliant on biological agents, conventional chemical
processing, fluorescent tags, gas chromatography or DNA analysis -- ONLY
CLEAN WATER.
MIT has demonstrated the ability to detect and identify, within several
minutes, the microbes Escherichia coli, Listeria, Salmonella,
Staphylococcus aureus, and other pathogenic bacteria. MIT recently
performed over 300 tests for the identification of these contaminants and
scored an accuracy of 95 percent -- significantly better than other
processes. The MIT System can currently identify 23 species of bacteria and
this recognition capability is easily expandable. The identification
process has been verified by North American Science Associates, Inc.
(NAMSA), an independent, internationally recognized biological testing
laboratory. The NAMSA Test Report, in the Company's opinion, demonstrated
the accuracy, speed and efficiency of the MIT System over conventional
processes and is available from the Company. The Company also recently
engaged the Association of Official Analytical Chemists (AOAC) which is the
authoritative source of certifying analytical methods for both agricultural
and food products used worldwide.
This release contains statements that are forward-looking in nature.
Statements that are predictive in nature, that depend upon or refer to
future events or conditions or that include words such as "expects,"
"anticipates," "intends," "plans," "believes," "estimates," and similar
expressions are forward-looking statements. These statements are made
based upon information available to the Company as of the date of this
release, and we assume no obligation to update any such forward-looking
statements. These statements are not guarantees of future performance and
actual results could differ materially from our current expectations.
Factors that could cause or contribute to such differences include, but are
not limited to dependence on suppliers; short product life cycles and
reductions in unit selling prices; delays in development or shipment of new
products; lack of market acceptance of our new products or services;
inability to continue to develop competitive new products and services on a
timely basis; introduction of new products or services by major
competitors; our ability to attract and retain qualified employees;
inability to expand our operations to support increased growth; and
declining economic conditions, including a recession. These and other
factors and risks associated with our business are discussed from time to
time within our filings with the Securities and Exchange Commission.
Contact Information: CONTACT:
Michael Brennan
Chairman
Email:
Telephone: (805) 557-0614